Advertisement
Advertisement
U.S. Markets closed
Advertisement
Advertisement
Advertisement
Advertisement

AtriCure, Inc. (ATRC)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
38.35-1.24 (-3.13%)
At close: 04:00PM EDT
38.35 0.00 (0.00%)
After hours: 04:02PM EDT
Advertisement

AtriCure, Inc.

7555 Innovation Way
Mason, OH 45040
United States
513 755 4100
https://www.atricure.com

Sector(s)Healthcare
IndustryMedical Instruments & Supplies
Full Time Employees875

Key Executives

NameTitlePayExercisedYear Born
Mr. Michael H. CarrelCEO, Pres & Director1.94M10.85M1971
Ms. Angela L. Wirick CPAChief Financial Officer694.64kN/A1978
Mr. Douglas J. SeithChief Operating Officer1.17MN/A1966
Dr. Vinayak Doraiswamy Ph.D.Chief Scientific Officer777.66kN/A1972
Mr. Justin J. NozneskyChief Marketing & Strategy Officer700.74k1.95M1978
Mr. Salvatore Privitera J.D.Chief Technical OfficerN/AN/A1967
Mr. Karl S. Dahlquist C.C.E.P., CCEP, J.D.Chief Legal & Compliance OfficerN/AN/A1970
Valerie Storch-WillhausVP of Corp. Marketing & CommunicationsN/AN/AN/A
Ms. Tonya A. Austin SPHRSr. VP of HRN/AN/A1972
Ms. Deborah YountChief HR OfficerN/AN/AN/A
Amounts are as of December 31, 2021 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation devices, such as the MAX Pen device that enables surgeons to evaluate cardiac arrhythmias, perform temporary cardiac pacing, sensing, and stimulation and ablate cardiac tissue with the same device; and the Coolrail device, which enable users to make longer linear lines of ablation. It also provides cryoICE Cryoablation System that enables the user to make linear ablations of varied lengths; EPi-Sense Guided Coagulation System, a single-use disposable device used for the treatment of symptomatic, drug-refractory, and long-standing persistent atrial fibrillation; AtriClip System, an implantable device coupled to a single-use disposable applier; and LARIAT System, a suture-based solution for soft-tissue closure compatible with a range of anatomical shapes. In addition, the company sells Lumitip Dissectors to separate tissues to provide access to key anatomical structures that are targeted for ablation; Glidepath guides for placement of clamps; Subtle Cannula's to support access for EPi-Sense catheters; and various reusable cardiac surgery instruments, which are used during surgical procedures for repair or replacement of certain heart valves. It markets and sells its products through independent distributors and direct sales personnel. The company was incorporated in 2000 and is headquartered in Mason, Ohio.

Corporate Governance

AtriCure, Inc.’s ISS Governance QualityScore as of July 1, 2022 is 1. The pillar scores are Audit: 2; Board: 1; Shareholder Rights: 3; Compensation: 1.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Advertisement
Advertisement